Human leukocyte antigen–DR isotype (major histocompatibility complex class II) expression in different types of endometriosis

BACKGROUND: Disorders of the immune system, which regulates adhesion, invasion, proliferation, apoptosis, and neoangiogenesis, are essential in the development of endometriosis. At the same time, a significant role is assigned to the immunogenetic aspects of the progression of endometriosis, in particular, the influence of major histocompatibility complex, or human leukocyte antigens, on the regulation of the immune system in this disease. However, characteristic features of its expression in different types of endometriosis are poorly understood. AIM: The aim of this study was to determine the human leukocyte antigen–DR isotype (major histocompatibility complex class II) (HLA-DR) expression characteristics in endometrioid heterotopias in different types of endometriosis such as adenomyosis, endometrial ovarian cysts, and extragenital endometriosis.

This retrospective study was performed based on morphological and immunohistochemical studies of surgical material. The latter was carried out using the standard avidin-biotin complex method using mouse monoclonal antibodies specific to HLA-DR (class II).

The study included 329 women aged 18 to 47 years who underwent surgical interventions for endometriosis of various organ localizations: 98 cases of internal genital endometriosis (adenomyosis), 196 cases of endometrial ovarian cysts, and 35 cases of extragenital endometriosis (21 cases of postoperative scar endometriosis and 14 cases of endometriosis of various parts of the intestine). Regardless of the organ localization of endometriosis, a clear pattern of HLA-DR (class II) expression was found. HLA-DR positive cells were found in the stroma of adenomyosis foci, in the capsules of endometrial ovarian cysts, and in extragenital heterotopias. They were more common in postoperative scar endometriosis—79 [75; 104], intestinal endometriosis—55 [50; 59], adenomyosis—56 [32; 97], and in endometrial ovarian cysts, their expression value was 14 [10; 63]. The glandular epithelium in endometrial heterotopias with signs of proliferation or secretion was HLA-DR negative in all the studied types of endometriosis—in adenomyosis, postoperative scar endometriosis, and intestinal endometriosis. Positive HLA-DR (class II) expression was found only in the epithelial lining of cystically transformed glands in adenomyosis foci and extragenital sites of endometriosis. The largest number of HLA-DR positive epithelial cells was found in the epithelial lining of endometrial ovarian cysts, the expression intensity being weak in 12.3%, intermediate in 72.3%, and strong in 15.4% of cases.

The data obtained suggest that the HLA-DR positive phenotype of endometriosis may reflect a specific morphogenesis and abnormalities in the cell genome associated with chronic inflammation, which is important in the prognosis of the clinical course of the disease. Further comprehensive clinical, morphological, and molecular genetic studies are required. Full Text About the authors Victoria A. Pechenikova North-Western State Medical University named after I.I. Mechnikov Author for correspondence. Email: [email protected] ORCID iD: 0000-0001-5322-708X SPIN-code: 9603-5645 MD, Dr. Sci. (Medicine), Professor Russian Federation, Saint PetersburgNikol N. Pertovskaia North-Western State Medical University named after I.I. Mechnikov Email: [email protected] ORCID iD: 0000-0001-6849-5335 SPIN-code: 7769-1969 MD, Cand. Sci. (Medicine) Russian Federation, Saint PetersburgArtem O. Safronov North-Western State Medical University named after I.I. Mechnikov Email: [email protected] ORCID iD: 0000-0001-6625-2479 SPIN-code: 6180-8844 Russian Federation, Saint Petersburg

- Adamyan LV, Arslanyan KN, Loginova ON, et al. Immunological aspects of endometriosis: review of the literature. Lechaschi vrach. 2020;(4):37–47. (In Russ.) doi: 10.26295/OS.2020.29.10.007 - Symons LK, Miller JE, Kay VR, et al. The immunopathophysiology of endometriosis. Trends Mol Med. 2018;24(9):748–762. EDN: YHTFMD doi: 10.1016/j.molmed.2018.07.004 - Chiang CM, Hill JA. Localization of T cells, interferon-gamma and HLA-DR in eutopic and ectopic human endometrium. Gynecol Obstet Invest. 1997;43(4):245–250. doi: 10.1159/000291866 - Ota H, Igarashi S. Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis. Fertil Steril. 1993;60(5):834–838. doi: 10.1016/s0015-0282(16)56284-0 - Baka S, Frangou-Plemenou M, Panagiotopoulou E, et al. The expression of human leukocyte antigens class I and II in women with endometriosis or adenomyosis. Gynecol Endocrinol. 2011;27(6):419–424. doi: 10.3109/09513590.2010.495429 - Guarene M, Capittini C, De Silvestri A, et al. Targeting the immunogenetic diseases with the appropriate HLA molecular typing: critical appraisal on 2666 patients typed in one single centre. Biomed Res Int. 2013;2013:904247. doi: 10.1155/2013/904247 - Nordquist H, Jamil RT. Biochemistry, HLA Antigens. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2024. [cited 2024 Dec 26]. Available from: https://pubmed.ncbi.nlm.nih.gov/31536268/ - Troshina EA, Yukina MYu, Nuralieva NF, et al. The role of HLA genes: from autoimmune diseases to COVID-19. Problems of Endocrinology. 2020;66(4):9–15. EDN: FXVGYQ doi: 10.14341/probl12470 - Ho HN, Chao KH, Chen HF, et al. Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis. Hum Reprod. 1995;10(10):2671–2675. EDN: IPDEVX doi: 10.1093/oxfordjournals.humrep.a135765 - Králíčková M, Vetvicka V. Immunological aspects of endometriosis: a review. Ann Transl Med. 2015;3(11):153. EDN: YYGRBR doi: 10.3978/j.issn.2305-5839.2015.06.08 - Yan J, Zhou L, Liu M, et al. Single-cell analysis reveals insights into epithelial abnormalities in ovarian endometriosis. Cell Rep. 2024;43(3):113716. EDN: YOHNAR doi: 10.1016/j.celrep.2024.113716 - Liu Y, Luo L, Zhao H. Immunohistochemical study of HLA-DR antigen in endometrial tissue of patients with endometriosis. J Huazhong Univ Sci Technolog Med Sci. 2002;22(1):60–61. doi: 10.1007/BF02904791 - Maxwell C, Kilpatrick DC, Haining R, et al. No HLA-DR specificity is associated with endometriosis. Tissue Antigens. 1989;34(2):145–147. doi: 10.1111/j.1399-0039.1989.tb01729.x - Koumantakis EE, Panayiotides JG, Goumenou AG, et al. Different HLA-DR expression in endometriotic and adenomyotic lesions: correlation with transvaginal ultrasonography findings. Arch Gynecol Obstet. 2010;281(5):851–856. doi: 10.1007/s00404-009-1168-z - Ellinidi VN, Smaglenko EA, Pechenikova VA, et al. Human leukocyte antigen, isotype DR (HLA-DR) expression in the normal endometrium and in endometrial pathology. Journal of Obstetrics and Women’s Diseases. 2024;73(5):96–104. EDN: FSOUXH doi: 10.17816/JOWD632930